Myoblast cell therapy shows promise, but safety issues linger.
Kahn
Jason
J
Cardiovascular Research Foundation, New York, New York 10022-1122, USA. jkahn@crf.org
D001145:Arrhythmias, Cardiac / Q000209:etiology* / Q000503:physiopathology; D006348:Cardiac Surgical Procedures; D017690:Cell Transplantation / Q000009:adverse effects; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D006801:Humans; D032448:Myoblasts, Skeletal / Q000637:transplantation*; D009203:Myocardial Infarction / Q000503:physiopathology / Q000601:surgery*; D013318:Stroke Volume; D020257:Ventricular Remodeling